header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

THE PROTEK CLS TOTAL HIP REPLACEMENT



Abstract

Between June 1986 and 1993, 208 Protek CLS total hip replacements were inserted in 174 patients. These have been reviewed clinically and radiologically by independent observers at 3 yearly intervals.

One hundred and sixty six hips in 137 patients were available for review 9 to 15.5 years from insertion (mean just over 10.5 years). There has been no significant clinical or radiological change when compared to reviews three and six years ago with regard to the Harris Hip Score and the pain and function components of this. There has also been no change in subsidence, heterotopic ossification or lucencies. There has been no significant difference in results between males or females, nor between other factors such as pre-operative diagnosis, the use of metal or ceramic heads, age at time of operation or length of follow up. The failure rate remains low, less than 4%, i.e. survival rate greater than 96%. The reasons for failure in general do not relate to the fixation of either the acetabular or femoral components.

The results of this long-term follow up of a large group of relatively young patients at time of insertion of arthroplasty remain very satisfactory.

Correspondence should be addressed to the editorial secretary: Associate Professor Jean-Claude Theis, Department of Orthopaedic Surgery, Dunedin Hospital, Private Bag 1921, Dunedin, New Zealand.